Safety and Efficacy of Individual Batches of ATG-F in Kidney Transplant Recipients: Multicentre, Prospective, Observational Study
Phase of Trial: Phase IV
Latest Information Update: 26 May 2017
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 13 Oct 2016 Planned End Date changed from 1 Nov 2017 to 1 Mar 2018.
- 13 Oct 2016 Planned primary completion date changed from 1 Nov 2017 to 1 Mar 2018.
- 25 Mar 2015 New trial record